Invention Grant
- Patent Title: Pharmaceutical composition comprising PDE9 inhibitor
-
Application No.: US16609514Application Date: 2018-05-30
-
Publication No.: US11484502B2Publication Date: 2022-11-01
- Inventor: Edgar Schuck , Robert Lai , Ishani Savant Landry , Bhaskar Rege , Mai Miyamoto , Sadaharu Kotani , Kanta Horie
- Applicant: Eisai R&D Management Co., Ltd.
- Applicant Address: JP Tokyo
- Assignee: Eisai R&D Management Co., Ltd.
- Current Assignee: Eisai R&D Management Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Fish & Richardson P.C.
- International Application: PCT/JP2018/020643 WO 20180530
- International Announcement: WO2018/221546 WO 20181206
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61P25/28 ; A61K9/16 ; A61K9/48 ; A61K31/437
Abstract:
The present invention provides a pharmaceutical composition comprising a PDE9 inhibitor. Specifically, the PDE9 inhibitor is (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quin olin-4(5H)-one or pharmaceutically acceptable salts thereof.
Public/Granted literature
- US20200078306A1 PHARMACEUTICAL COMPOSITION COMPRISING PDE9 INHIBITOR Public/Granted day:2020-03-12
Information query
